Published in Blood Weekly, June 19th, 2003
S. Giebel and colleagues at the University of Pavia and IRCSS Policlinico San Matteo in Pavia, Italy and the Silesian Medical Academy in Katowice, Poland examined the utility of high-resolution molecular HLA typing of URD stem cells.
Children whose stem cell donors were chosen by the results of molecular typing had a low risk of graft rejection or graft-versus-host disease (GVHD), Giebel and coauthors reported.
They assessed the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.